Randomized Phase 2, Dose-finding Efficacy, Safety Study of ANF-RHO™ Versus Neulasta® in Chemotherapy-Induced Neutropenia
Clinical trial NCT03559387 · TERMINATED
Trial details
- NCT number
- NCT03559387
- Sponsor
- Prolong Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-03
- Primary completion
- 2018-04-18
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.